Search hospitals
>
California
>
Oakland
Kaiser Permanente-Oakland
Claim this profile
Oakland, California 94611
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Brain Tumor
Conducts research for Lymphoma
450 reported clinical trials
12 medical researchers
Summary
Kaiser Permanente-Oakland is a medical facility located in Oakland, California. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Brain Tumor, Lymphoma and other specialties. Kaiser Permanente-Oakland is involved with conducting 450 clinical trials across 608 conditions. There are 12 research doctors associated with this hospital, such as Aarati Rao, Laura A. Campbell, Jennifer M. Suga, and Tatjana Kolevska, MD.
Area of expertise
Breast Cancer
Kaiser Permanente-Oakland has run 68 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Kaiser Permanente-Oakland has run 65 trials for Cancer. Some of their research focus areas include:
Top PIs
Aarati Rao
Kaiser Permanente-Oakland
6 years of reported clinical research
Laura A. Campbell
Kaiser Permanente-Oakland
8 years of reported clinical research
Jennifer M. Suga
Kaiser Permanente-Oakland
2 years of reported clinical research
Tatjana Kolevska, MD
Kaiser Permanente-Vallejo
3 years of reported clinical research
Clinical Trials running at Kaiser Permanente-Oakland
Lung Cancer
Skin Cancer
Breast Cancer
Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Testicular cancer
Melanoma
Brain Tumor
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Sacituzumab Tirumotecan vs Standard Therapy
for Lung Cancer
The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squamous non-small cell lung cancer (NSCLC). Participants in this study have NSCLC that has continued to progress on prior treatment with EGFR tyrosine kinase inhibitors (TKIs). The primary hypotheses of this study are that sacituzumab tirumotecan is better than platinum-based doublet chemotherapy (pemetrexed and carboplatin) in regard to progression-free survival (PFS) and overall survival (OS).
Recruiting
2 awards
Phase 3
2 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-Oakland?
Kaiser Permanente-Oakland is a medical facility located in Oakland, California. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Brain Tumor, Lymphoma and other specialties. Kaiser Permanente-Oakland is involved with conducting 450 clinical trials across 608 conditions. There are 12 research doctors associated with this hospital, such as Aarati Rao, Laura A. Campbell, Jennifer M. Suga, and Tatjana Kolevska, MD.
Where is Kaiser Permanente-Oakland located?
Kaiser Permanente Oakland Hospital is located at 3600 Broadway, Oakland, CA 94611. The emergency entrance is at the intersection of Broadway and MacArthur Boulevard, near I-580 and Hwy. 24.
Who should I call to ask about financial aid or insurance network?
**Kaiser Permanente-Oakland Hospital** - **Location:** 3600 Broadway, Oakland, CA 94611 - **General Information:** Call 510-752-1000 - **Financial Assistance:** Contact the Medical Financial Assistance Program at 800-390-3507 - **Insurance Inquiries:** Reach out to the Member Services Contact Center at 800-464-4000 - **Business Hours:** Monday through Friday, 9 a.m. to 4:30 p.m. for state disability and simple claims forms assistance.
What insurance does Kaiser Permanente-Oakland accept?
Kaiser Permanente-Oakland accepts various insurance plans, including those from the Kaiser Foundation Health Plan in Northern California. Coverage levels range from Bronze, with the lowest monthly premium and highest deductible, to Platinum, featuring the highest monthly premium and lowest out-of-pocket costs. The Oakland Medical Center-Kaiser Permanente specifically accepts Exclusive Provider Organization (EPO) plans, necessitating the use of hospitals and doctors within the plan's network.
What awards or recognition has Kaiser Permanente-Oakland received?
Kaiser Permanente-Oakland hospital, located in Oakland, California, is celebrated for its exceptional patient care, earning recognition from the Leapfrog Group and placing it in the top 6% of hospitals nationwide. It is also home to the Kaiser Permanente Division of Research, known for its extensive research program. This program has published over 2,600 papers in fields like epidemiology and health services, with funding from federal agencies, The Permanente Medical Group, and the Kaiser Foundation Health Plan's Community Benefit Program.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.